Thermoregulatory responses to lipopolysaccharide in the mouse: dependence on the dose and ambient temperature

2005 ◽  
Vol 289 (5) ◽  
pp. R1244-R1252 ◽  
Author(s):  
Alla Y. Rudaya ◽  
Alexandre A. Steiner ◽  
Jared R. Robbins ◽  
Alexander S. Dragic ◽  
Andrej A. Romanovsky

Most published studies of thermoregulatory responses of mice to LPS involved a stressful injection of LPS, were run at a poorly controlled and often subneutral ambient temperature (Ta), and paid little attention to the dependence of the response on the LPS dose. These pitfalls have been overcome in the present study. Male C57BL/6 mice implanted with jugular vein catheters were kept in an environmental chamber at a tightly controlled Ta. The relationship between the Tas used and the thermoneutral zone of the mice was verified by measuring tail skin temperature, either by infrared thermography or thermocouple thermometry. Escherichia coli LPS in a wide dose range (100-104μg/kg) was administered through an extension of the jugular catheter from outside the chamber. The responses observed were dose dependent. At a neutral Ta, low (just suprathreshold) doses of LPS (100-101μg/kg) caused a monophasic fever. To a slightly higher dose (101.5μg/kg), the mice responded with a biphasic fever. To even higher doses (101.75-104μg/kg), they responded with a polyphasic fever, of which three distinct phases were identified. The dose dependence and dynamics of LPS fever in the mouse appeared to be remarkably similar to those seen in the rat. However, the thermoregulatory response of mice to LPS in a subthermoneutral environment is remarkably different from that of rats. Although very high doses of LPS (104μg/kg) did cause a late (latency, ∼3 h) hypothermic response in mice, the typical early (latency, 10–30 min) hypothermic response seen in rats did not occur. The present investigation identifies experimental conditions to study LPS-induced mono-, bi-, and polyphasic fevers and late hypothermia in mice and provides detailed characteristics of these responses.

1994 ◽  
Vol 13 (5) ◽  
pp. 337-343 ◽  
Author(s):  
Olga Siroki ◽  
L. Institoris ◽  
E. Tatar ◽  
I. Desi

The toxicity of a new pyrethroid pesticide Supercypermethrin Forte (SCMF) was studied in male CFLP mice using classic toxicological (body weight, organ weights) and haematological (white blood cell count, haematocrit, nucleated cell content of femoral bone marrow) methods and immune function tests (PFC assay, DTH reaction). Four weeks of oral treatment in a 5 days per week system at doses of 1/10, 1/20, or 1/40 x LD50 did not cause evaluable changes in the measured parameters. When single calculated LD20, LD10, or LD5 doses of SCMF were administered on different days before termination to different groups of mice the two higher doses caused a time- and dose-dependent decrease in the splenic PCF number, Apart from some temporary toxic signs and an increase of haematocrit at the top dose the other examined parameters did not show evaluable changes. Under these experimental conditions toxic changes appeared only at the high dose range and, of those applied, the PFC assay proved to be the most sensitive method for detecting the toxicity of SCMF.


1997 ◽  
Vol 273 (1) ◽  
pp. R407-R413 ◽  
Author(s):  
A. A. Romanovsky ◽  
C. T. Simons ◽  
M. Szekely ◽  
V. A. Kulchitsky

Experimentally, systemic inflammation induced by a bolus intravenous injection of lipopolysaccharide (LPS) may be accompanied by three different thermoregulatory responses: monophasic fever (the typical response to low doses of LPS), biphasic fever (medium doses), and hypothermia (high doses). In our recent study [Romanovsky, A. A., V. A. Kulchitsky, C. T. Simons, N. Sugimoto, and M. Szekely. Am. J. Physiol. (Regulatory Integrative Comp. Physiol.). In press], monophasic fever did not occur in subdiaphragmatically vagotomized rats. In the present work, we asked whether vagotomy affects the two other types of thermoregulatory response. Adult Wistar rats were vagotomized (or sham operated) and had an intravenous catheter implanted. On day 28 postvagotomy, the thermal responses to the intravenous injection of Escherichia coli LPS (0, 1, 10, 100, or 1,000 micrograms/kg) were tested in either a neutral (30 degrees C) or slightly cool (25 degrees C) environment. Three major results were obtained. 1) In the sham-operated rats, the 1 microgram/kg dose of LPS caused at 30 degrees C a monophasic fever with a maximal colonic temperature (Tc) rise of approximately 0.6 degree C; this response was abated (no Tc changes) in the vagotomized rats. 2) At 30 degrees C, all responses to higher doses of LPS (10-1,000 micrograms/kg) were represented by biphasic fevers (the higher the dose, the less pronounced the first and the more pronounced the second phase was); none of these biphasic fevers was altered in the vagotomized animals. 3) In response to the 1,000 micrograms/kg dose at 25 degrees C, hypothermia occurred: Tc changed by -0.5 +/- 0.1 degree C (nadir); this hypothermia was exaggerated (-1.1 +/- 0.1 degrees C) in the vagotomized rats. It is concluded that vagal afferentation may be important in the mediation of the response to minor amounts of circulating LPS, whereas the response to larger amounts is brought about mostly (if not exclusively) by nonvagal mechanisms. This difference may be explained by the dose-dependent mechanisms of the processing of exogenous pyrogens. Vagotomized animals also appear to be more sensitive to the hypothermizing action of LPS in a cool environment; the mechanisms of this phenomenon remain speculative.


2014 ◽  
Vol 2014 ◽  
pp. 1-11 ◽  
Author(s):  
Vijayapandi Pandy ◽  
Megala Narasingam ◽  
Thubasni Kunasegaran ◽  
Dharmani Devi Murugan ◽  
Zahurin Mohamed

This study examined the effect of methanolic extract ofMorinda citrifoliaLinn. (MMC) and its bioactive principles, scopoletin and rutin, on dopamine- and noradrenaline-evoked contractility in isolated rat vas deferens preparations. MMC (1–40 mg/mL), scopoletin (1–200 μg/mL), and rutin hydrate (0.6–312.6 μg/mL) dose-dependently inhibited the contractility evoked by submaximal concentrations of both dopamine and noradrenaline, respectively. Haloperidol and prazosin, reference dopamine D2, andα1-adrenoceptors antagonists significantly reversed the dopamine- and noradrenaline-induced contractions, respectively, in a dose-dependent manner. Interestingly, MMCper seat higher doses (60–100 mg/mL) showed dose-dependent contractile response in rat vas deferens which was partially inhibited by high doses of haloperidol but not by prazosin. These results demonstrated the biphasic effects of MMC on dopaminergic system; that is, antidopaminergic effect at lower concentrations (<40 mg/mL) and dopaminergic agonistic effect at higher concentrations (>60 mg/mL). However, similar contractile response at high doses of scopoletin (0.5–5 mg/mL) and rutin hydrate (0.5–5 mg/mL)per sewas not observed. Therefore, it can be concluded that the bioactive principles of MMC, scopoletin, and rutin might be responsible for the antidopaminergic and antiadrenergic activities of MMC.


2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S31-S32
Author(s):  
Katsuhiko Hagi ◽  
Nosaka Tadashi ◽  
Andrei Pikalov

Abstract Background Lurasidone is once a day oral medication, which could be administered any time of the day, but the relationship between the timing of administration and the risk of developing adverse events has not been systematically evaluated. The purpose of this study was to examine whether there is a difference in the risk of adverse events between lurasidone administration in the morning and at night in the treatment of adult schizophrenia. Methods Randomized placebo-controlled trials (RCTs) of lurasidone in adults with acute exacerbation of schizophrenia were analyzed for the incidence of akathisia, somnolence, and nausea. We compared the risk of each adverse event and the risk differences (RDs) for each lurasidone dose versus placebo in patients taking lurasidone in the morning (AM dosing group) and those taking lurasidone at night (PM dosing group). Results Nine RCTs were included in the analysis (six RCTs with AM dosing and three RCTs with PM dosing). In the AM dosing group, lurasidone doses of 20, 40, 80, and 120 mg/day were evaluated, and in the PM dosing group, lurasidone doses of 20, 40, 80, and 160 mg/day were evaluated. The risk of akathisia increased in a dose-dependent manner in AM dosing group, this tendency, however, was not observed in PM dosing group. In addition, RD tended to be larger in AM dosing group than in PM dosing group at the same dose [AM dosing group: 20 mg/day=-4.1%, no significantly different from placebo (ns); 40 mg/day=7.1%, p&lt;0.001; 80 mg/day=9.1%, p&lt;0.001; 120 mg/day=20.3%, p&lt;0.001, PM dosing group: 20 mg/day=3.2%, ns; 40 mg/day=2.3%, ns; 80 mg/day=8,7%, p&lt;0.001; 160 mg/day=6.5%, p&lt;0.01]. Similarly, the risk of somnolence increased in a dose-dependent manner in AM dosing group, however, this tendency was not clearly observed in PM dosing group. RD tended to be larger in AM dosing group than in PM dosing group at the same dose (AM dosing group: 20 mg/day=0.1%, ns; 40 mg/day=3.6%, p&lt;0.05; 80 mg/day=4.9%, p&lt;0.01; 120 mg/day=9.3%, p&lt;0.001, PM dosing group: 20 mg/day=-0.4%, ns; 40 mg/day=2.8%, p&lt;0.05: 80 mg/day=0.2%, ns; 160 mg/day=5.8%, p&lt;0.05). There was no clear dose-dependent trend associated with nausea and RD was similar between AM and PM dosing group (AM dosing group: 20 mg/day=0.2% ns; 40 mg/day=3.8%, p&lt;0.05; 80 mg/day=3.8%, ns; 120 mg/day=6.6%, ns, PM dosing group: 20 mg/day=-1.6%, ns; 40 mg/day=-1.7%, ns; 80 mg/day=5.5%, p&lt;0.01; 160 mg/day=2.8%, ns). Discussion The risk of adverse events in the treatment of schizophrenia with lurasidone can vary depending on the timing of administration. In particular, for akathisia and somnolence, the incidence risks were reduced when lurasidone was administered in PM. Unlike with AM administration, the dose-dependence in the risks of these adverse events were not observed in lurasidone PM administration. The timing of lurasidone administration could be considered in effort to minimize potential adverse events.


1976 ◽  
Vol 231 (1) ◽  
pp. 148-152 ◽  
Author(s):  
R Francesconi ◽  
M Mager

Exogenously administered monoamines may elicit variable thermoregulatory responses dependent on dosage, species, site of administration, ambient temperature, etc. In an attempt to reconcile several inconsistencies, we have undertaken a series of studies related to monoaminergic control of temperature regulation. Thus, intraventricular administration of serotonin (2.64-26.4 mug) and norepinephrine (3.3-32.8 mug) in rats evoked acute (15-60 min) dose-dependent hypothermic responses (delta Tre = 2 degrees C) that were gradually superseded by significant, more persistent hyperthermia (delta Tre = 1 degreee C). Administration of chlorimipramine or imipramine (total dose 40 mug), even in monoamine-depleted animals, caused long-lasting hyperthermic responses, presumably by the prevention of reuptake of serotonin and norepinephrine at nerve terminals involved in thermoregulation. Pretreatment with the serotonin inhibitor cyproheptadine (4o mug) attenuated the hyperthermia achieved by central administration of chlorimipramine alone. We conclude that both monoamines can act as thermogenic agents under the conditions of these experiments.


1992 ◽  
Vol 7 (1) ◽  
pp. 33-37
Author(s):  
IR de Oliveira ◽  
PR Brito ◽  
MF Peres ◽  
R Dardennes ◽  
MA da Rocha-Junior ◽  
...  

SummaryThis study was designed to verify whether fluoxetine (FL), a serotonin (5-HT) re-uptake inhibitor, would interfere with nortriptyline (NT), a biphasic U-shaped curvilinear dose-response relationship recently described in our laboratory. We associated 10 mg/kg NT or vehicle to 0, 5, 10, 20 and 40 mg/kg FL, in one group, and 10 mg FL or vehicle to 0, 5, 10, 20 and 40 mg/kg NT, in another group, 30 min before the tail suspension test (TST) in mice. Although we were not able to confirm a synergistic effect between FL and NT, FL-NT association seems to require higher doses of NT to block its own anti-immobility effect at high doses, thus widening NT effective antidepressant-like dose range in mice submitted to TST.


1975 ◽  
Vol 141 (5) ◽  
pp. 1084-1100 ◽  
Author(s):  
Y A Sidky ◽  
R Auerbach

A new and sensitive assay for the effect of intracutanous administration of immunocompentent lymphocytes into the skin of irradiated unimmunized mice is described. The assay, which we have termed lymphocyte-induced angiogenesis (LIA) involves enumeration of new vascular branches induced by the action of these competent cells. As is the case for the previously described normal lymphocyte transfer reaction, LIA is a manifestation of the graft-vs.-host reaction, as shown by experiments utilizing appropaiate genetic combinations. The reaction is dose-dependent, and within the dose range of 2 times 10 minus 5 -4 times 10-6 cells the mumber of vessels induced correlates with the mumber of immunocompetent cells injected. At these dose levels spleen, lumph node, and hydrocortisone-resistant thymocytes are effective; bone marrow and thymus cells are not. Spleen cells from nude mice are incapable of inducing LIA, while mitomycin-C and irradiated lymphocytes can initiate but not maintain the reaction. The relationship between lymphocyte-induced angiogenesis has been discussed as have the implications of these findings to delayed hypersensitivity, inflammation, and vascular pathology.


1991 ◽  
Vol 6 (9) ◽  
pp. 1905-1912 ◽  
Author(s):  
Elizabeth L. Fleischer ◽  
M. Grant Norton ◽  
Mark A. Zaleski ◽  
William Hertl ◽  
C. Barry Carter ◽  
...  

Ion-channeling and transmission electron microscopy (TEM) techniques were used to examine the microstructure of single-crystal Y2O3 stabilized cubic zirconia (YSZ) after implantation with 240 keV Xe+ ions. The observed microstructure was related to Knoop indentation hardness measurements. These measurements showed an increase in hardness for low ion-doses, reaching some maximum value, then a decrease in hardness at higher doses. In the hardening regime, below 7.5 × 1015 Xe+/cm2, point defects and dislocation networks were observed by TEM. Ion-channeling showed a corresponding increase in damage as a function of ion-dose. For doses between 7.5 × 1015 and 3 × 1016 Xe+/cm2 the hardness falls, and the amount of damage, measured with ion-channeling, reaches a limiting value at less than complete damage. In this dose range the Xe concentration continues to increase beyond the dose where the amount of damage saturates. For high doses, greater than 3 × 1016 Xe+/cm2, where softening of the zirconia occurs, additional reflections appear in the electron diffraction pattern that are consistent with the lattice parameter of solid Xe. A diffuse ring is also visible; this is believed to be due to the presence of fluid Xe. Both ion-channeling and TEM show that a significant amount of monocrystalline zirconia remains even up to doses of 1 × 1017 Xe+/cm2. There is also evidence for the presence of recrystallized zirconia at the high doses. Since so much crystalline material remains, it seems that amorphization of the zirconia is not the dominant cause of the softening at high doses.


Author(s):  
Dakai Bian ◽  
Jason C. Tsui ◽  
Mikhail Repin ◽  
Guy Garty ◽  
Helen Turner ◽  
...  

Due to the need of high speed and efficient biodosimetric assays for triage and therapy in the event of radiological or nuclear attack, a robotically-based automated biodosimetry tool (RABiT) has been developed over the past few years. Adapting the micronucleus assay from filter plates to V-shaped plates presented challenges in the liquid handling, namely cell splashing out of the V-shaped well plate during the cell harvesting, poor cell distribution on the bottom of the image plate during the dispensing, and cell loss from the image plate during the aspiration in the liquid handling process. Experimental and numerical investigations were carried out to better understand the phenomena and mitigate the problems. Surface tension and contact angle among the fluids and the plate wall were accounted for in the discrete and multiphase numerical models. Experimental conditions were optimized based on the numerical results showing the relationship between nozzle speed and amount of splashed liquid, and the relationship between aspiration speed and number of escaped cells. Using these optimized parameters, numbers of micronuclei in binucleated cells showed the same dose dependence in the RABiT-prepared samples as those in the manually prepared ones. Micronucleus assay protocol was fully realized on RABiT.


1979 ◽  
Vol 81 (3) ◽  
pp. 315-323 ◽  
Author(s):  
FRITZ MÄRKI ◽  
BRUNO KAMBER ◽  
HANS RINK ◽  
PETER SIEBER

The effects of two [d-Cys14]-analogues of somatostatin on basal plasma levels of glucagon, insulin and glucose were determined in unanaesthetized rats to re-examine a glucagon-selective action of these peptides which has been claimed by others. Somatostatin, [d-Cys14]-somatostatin and [d-Trp8, d-Cys14]-somatostatin caused a short-lasting, dose-dependent decrease of plasma glucagon and insulin but they had no significant influence on plasma glucose. Glucagon and insulin reached the nadir 2 min after intravenous injection of the peptides (dose range 1–10 μg/kg) or 5 min after subcutaneous administration (30 and 300 μg/kg). At the nadir, insulin was decreased to a greater extent than glucagon and the effects of all three peptides were equipotent. However, in the period after the nadir and at high doses, the time-course of some effects of the analogues on either glucagon or insulin differed from that of somatostatin. Thus, these [d-Cys14]-analogues may show partial kinetic dissociation of effects on glucagon and insulin but they are not truly selective inhibitors of glucagon release.


Sign in / Sign up

Export Citation Format

Share Document